Other related webinars
Essential Regulatory Perspectives and Best Clini...
Monday, 7th February, 2011
Time : 01:00 PM EST | 10:00 AM PST
Biggest challenge for Pharmaceuticals/ Biotechno...
Tuesday, 22nd February, 2011
Time : 10:00 AM | 07:00 AM
Critical aspects of applying QbD to pharmaceutic...
Friday, 6th May, 2011
Time : 02:00 PM | 11:00 AM
Biologics Battlefield: Opportunities and Obstacl...
Thursday, 30th June, 2011
Time : 02:00 PM | 11:00 AM
Vital Success/Failure Regulatory Perspectives an...
Thursday, 15th September, 2011
Time : 02:00 PM | 11:00 AM
Good Laboratory Practices (GLP) Compliance and A...
Friday, 11th November, 2011
Time : 02:00 PM | 11:00 AM
Good Clinical Practice (GCP): FDA Regulations, S...
Thursday, 26th January, 2012
Time : 02:00 PM EST | 11:00 AM PST
Orphan Drugs in Europe – How to use observatio...
Friday, 1st June, 2012
Time : 02:00 PM EST | 11:00 AM PST
Implementing the Compliant Good Laboratory Pract...
Friday, 10th August, 2012
Time : 02:00 PM EST | 11:00 AM PST
An overview of an innovative patient-centric ser...
Wednesday, 12th September, 2012
Time : 02:00 PM EST | 11:00 AM PST
An overview of Translational Medicine
Friday, 21st September, 2012
Time : 02:00 PM EST | 11:00 AM PST
Optimizing Site Selection for Global Clinical Tr...
Friday, 26th October, 2012
Time : 02:00 PM EST | 11:00 AM PST
Optimal clinical supply planning for global drug...
Friday, 16th November, 2012
Time : 02:00 PM EST | 11:00 AM PST
Patient Recruitment & Retention Management in Cl...
Monday, 10th December, 2012
Time : 02:00 PM EST | 11:00 AM PST
GMP's for Dietary Supplements: Keys to Success w...
Thursday, 30th October, 2014
Time : 01:00 PM EST | 10:00 AM PST
Is It Safe? A Cautionary Tale and Practical Guid...
Friday, 9th January, 2015
Time : 02:00 PM EST | 11:00 AM PST
How To Reconcile ICH GCP With RISK BASED Monitor...
Thursday, 19th March, 2015
Time : 11:00 AM IST | 06:30 PM BET
Orphan Drugs : Regulation and Reimbursement Cond...
Friday, 22nd July, 2016
Time : 01:00 PM EST | 10:00 AM PST
Panel Discussion on Best Practices to Clinical T...
Friday, 10th March, 2017
Time : 04:00 PM IST | 11:30 AM BST
FDA Requirements for Good Clinical Practice’s ...
Friday, 7th July, 2017
Time : 04:00 PM IST | 11:30 AM BST
Implementation of Pharmaceutical Quality system ...
Friday, 17th November, 2017
Time : 01:00 PM EST | 10:30 AM PST
FDA Guidance for ICH GCP E6 R2 Means for Sponsor...
Thursday, 27th September, 2018
Time : 04:00 PM IST | 03:30 AM PDT
Managing Human Error in Quality Systems: Human E...
Friday, 17th July, 2020
Time : 01:00 PM EST | 10:00AM PST
FDA approvals of Orphan Drugs and Rare Diseases:...
Friday, 24th July, 2020
Time : 01:00 PM EST | 10:30 AM PST
FDA approvals of Orphan Drugs and Rare Diseases:...
Friday, 26th August, 2022
Time : 01:00 PM EST | 10:00 AM PST
Good Documentation Guideline (Chapter <1029> USP...
Friday, 11th November, 2022
Time : 01:00 PM EDT | 10:00 AM PST
FDA - Investigating OOS results
Friday, 17th March, 2023
Time : 01:00 PM EDT | 10:00 AM PDT
Best Practices for FDA's Investigating Deviation...
Friday, 26th May, 2023
Time : 01:00 PM EDT | 10:00 AM PDT
Recorded Webinar
Good Documentation Guideline (Chapter <1029> USP)
timelapse 60 mins with 10-15 mins of Q and A
Note:
This webinar occured in the past
Along with recorded webinar, copy of presentation slides will be shared
Recorded Webinar can be played unlimited times
Speaker/Presenter
Short Abstract
Good Documentation Practices (GDP) is a critical and essential part of a regulated environment (pharmaceutical and medical device manufacturing, R&D, laboratories and clinical trials). Compliance with GDP ensures an auditable account of work. It ensures integrity and control of documents and is a key requirement for a developed quality system
This training session will cover the US Pharmacopeia General Chapter <1029> and all aspects of GDP including practices for writing and correcting documentation.
This 60-min webinar will familiarize participants with USP Chapter <1029> on good documentation guidelines. This session will wrap up the general concept and will provide information as to what needs to be documented in certain records.
Why should you attend
If you are involved in any product manufacturing, knowing GDP regulations is a must for you. It prevents a lot of errors and minimizes the chance of being spotted by the regulatory bodies in their audits.
This webinar will familiarize participants with USP Chapter <1029> on good documentation guidelines. This session will wrap up the general concept and will provide information as to what needs to be documented in certain records.
Learning Highlights:
- History of the chapter as to how and why it was created
- Purpose of development of this chapter
- Principles of Good Documentation
- Data collection & recording
- Different types of GMP Documents
- Laboratory records
- Equipment-related documentation
- Deviations and investigations
- Batch records
- Certificate of Analysis (C of A)*
- Standard Operating Procedure (SOP)*
- Protocols & reports*
- Analytical procedures*
- Training documentation
Content Disclaimer
Contents in our website are from external websites. Links to and content from external website are provided for the convenience of users. Biopractice.com takes no responsibility for the content of such links and websites.